A Multicenter, Randomized, Double-Blind, Placebo-Controlled Ph2 Trial of Pacibekitug SC Quarterly or Monthly in Patients with Elevated hs-CRP and Chronic Kidney Disease: TRANQUILITY 90-Day Results

31 August 2025 (15:15 - 16:00)
Organised by: Logo
Add to my library
Congress Presentation Part of: New perspectives in cardiology (3) - Pharmacotherapy Biotherapies ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology